OAC
TARS icon

OMERS Administration Corp’s Tarsus Pharmaceuticals TARS Stock Holding History

OMERS Administration Corp’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,200
Closed -$606K – 1330
2025
Q3 		$606K Buy
+10,200
New +$502K ﹤0.01% 685
2025
Q1 		– Sell
-7,400
Closed -$410K – 1124
2024
Q4 		$410K Buy
+7,400
New +$336K ﹤0.01% 745

Other funds holding TARS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

OMERS Administration Corp's TARS Position: Q4 2025 in Review

OMERS Administration Corp sold out of Tarsus Pharmaceuticals (TARS) in Q4 2025, closing a stake of 10,200 shares — an estimated $606K sold.

OMERS Administration Corp first reported a position in TARS in Q4 2024 and held it in 2 quarters. The position peaked at $606K in Q3 2025. 246 funds tracked by Wall St. Rank hold TARS as of Q4 2025.

  • OMERS Administration Corp reported no remaining Tarsus Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 10,200 Tarsus Pharmaceuticals shares in Q4 2025, an estimated $606K.
  • OMERS Administration Corp first reported a position in Tarsus Pharmaceuticals in Q4 2024 and held it in 2 quarters.
  • OMERS Administration Corp's Tarsus Pharmaceuticals position peaked at $606K in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.